Innovative Pharmaceutical Biotech Net Income 2024

Innovative Pharmaceutical Biotech Net Income

-245.7 M HKD

Innovative Pharmaceutical Biotech Dividend yield

Ticker

399.HK

ISIN

BMG4783W1073

WKN

A1416X

In 2024, Innovative Pharmaceutical Biotech's profit amounted to -245.7 M HKD, a -636.42% increase from the 45.8 M HKD profit recorded in the previous year.

The Innovative Pharmaceutical Biotech Net Income history

YEARNET INCOME (undefined HKD)
2023-245.7
202245.8
2021-204.94
2020-211.12
2019-260.27
2018-231.05
2017-169.79
2016-236.87
2015-451.68
2014-550.3
2013-72.8
2012-123.9
20114.9
201011.3
2009476.2
2008-68.6
2007-64.2
2006-53
2005-41
2004-1,452.8

Innovative Pharmaceutical Biotech Aktienanalyse

What does Innovative Pharmaceutical Biotech do?

The company Innovative Pharmaceutical Biotech Ltd is a company that is active in the field of biotechnological and pharmaceutical research and development. The company has its roots in the research and development of innovative active substances and drugs. The company's history began in the 1990s, when a group of scientists came together to bundle their expertise and visions and develop innovative solutions in the field of active substance research. They founded Innovative Pharmaceutical Biotech Ltd as an independent company in 2000. The company's business model is based on the research and development of new active substances and drugs in the field of oncology, neurology, and immunology. The company follows an insistence-driven approach, aiming to develop active substances with innovative mechanisms of action that are superior to proven therapeutic approaches. Innovative Pharmaceutical Biotech Ltd collaborates with a broad network of partners and cooperation partners, including academic research institutions, clinical centers, biotech companies, and pharmaceutical companies. The company cooperates with companies from all over the world and operates worldwide. The company has various divisions, each focusing on the development of active substances and drugs in specific medical fields. In the oncology division, the company develops active substances and drugs for the treatment of cancer. In the neurology division, active substances and drugs for the treatment of neurological diseases such as Alzheimer's and Parkinson's are researched and developed. The immunology division of the company is dedicated to the development of active substances and drugs for the treatment of immune system diseases such as autoimmune diseases and inflammations. Over the years, the company has developed and launched a number of products. One of its most important products is an active substance for the treatment of breast cancer, which has shown promising results in clinical studies. The company has also developed a treatment for the relief of pain in cancer and other patients based on chemotherapy symptoms. In addition to its research and development efforts, Innovative Pharmaceutical Biotech Ltd attaches great importance to compliance with standards and regulations in the pharmaceutical and biotechnological industry. The company maintains strict quality control procedures and strives to adhere to the highest standards in drug manufacturing. Innovative Pharmaceutical Biotech Ltd sees itself as a pioneer in the pharmaceutical and biotechnological industry and takes pride in developing innovative solutions that have the potential to improve the lives of people around the world. The company has a variety of partners and cooperation partners worldwide and is proud to have a global presence in the field of biotechnological and pharmaceutical research and development. In summary, Innovative Pharmaceutical Biotech Ltd is a company that focuses on the research and development of innovative active substances and drugs that have the potential to improve the lives of people worldwide. The company collaborates with a broad network of partners and cooperation partners and maintains strict quality control procedures to adhere to the highest standards in drug manufacturing. The translation is as accurate as possible. Innovative Pharmaceutical Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Innovative Pharmaceutical Biotech's Profit Margins

The profit margins of Innovative Pharmaceutical Biotech represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Innovative Pharmaceutical Biotech's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Innovative Pharmaceutical Biotech's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Innovative Pharmaceutical Biotech's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Innovative Pharmaceutical Biotech’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Innovative Pharmaceutical Biotech Stock

How much profit has Innovative Pharmaceutical Biotech made this year?

Innovative Pharmaceutical Biotech has made -245.7 M HKD this year.

How has the profit developed compared to last year?

The profit has increased by -636.42% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Innovative Pharmaceutical Biotech publish its earnings?

Innovative Pharmaceutical Biotech publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Innovative Pharmaceutical Biotech?

The profits of Innovative Pharmaceutical Biotech are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Innovative Pharmaceutical Biotech?

You can learn more about the earnings of Innovative Pharmaceutical Biotech by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Innovative Pharmaceutical Biotech pay?

Over the past 12 months, Innovative Pharmaceutical Biotech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Innovative Pharmaceutical Biotech is expected to pay a dividend of 0 HKD.

What is the dividend yield of Innovative Pharmaceutical Biotech?

The current dividend yield of Innovative Pharmaceutical Biotech is .

When does Innovative Pharmaceutical Biotech pay dividends?

Innovative Pharmaceutical Biotech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Innovative Pharmaceutical Biotech?

Innovative Pharmaceutical Biotech paid dividends every year for the past 0 years.

What is the dividend of Innovative Pharmaceutical Biotech?

For the upcoming 12 months, dividends amounting to 0 HKD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Innovative Pharmaceutical Biotech located?

Innovative Pharmaceutical Biotech is assigned to the 'Industry' sector.

Wann musste ich die Aktien von Innovative Pharmaceutical Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Innovative Pharmaceutical Biotech from 12/31/2003 amounting to 0.02 HKD, you needed to have the stock in your portfolio before the ex-date on 12/10/2003.

When did Innovative Pharmaceutical Biotech pay the last dividend?

The last dividend was paid out on 12/31/2003.

What was the dividend of Innovative Pharmaceutical Biotech in the year 2023?

In the year 2023, Innovative Pharmaceutical Biotech distributed 0 HKD as dividends.

In which currency does Innovative Pharmaceutical Biotech pay out the dividend?

The dividends of Innovative Pharmaceutical Biotech are distributed in HKD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Innovative Pharmaceutical Biotech

Our stock analysis for Innovative Pharmaceutical Biotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Innovative Pharmaceutical Biotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.